Full-Time

Sr. Product Manager

Supply Chain

Posted on 6/30/2025

McKesson

McKesson

Healthcare distribution and logistics services provider

Compensation Overview

$115.5k - $192.5k/yr

+ 20% MIP + Target Salary of $140,000

Senior, Expert

Mason, OH, USA + 1 more

More locations: Irving, TX, USA

In Person

Category
Product Management
Supply Chain Management
Operations & Logistics
Product
Required Skills
Inventory Management
Product Management
Data Analysis
Requirements
  • Degree or equivalent and typically requires 7+ years of relevant experience.
  • Bachelor’s degree in Supply Chain, Business, or related field or related experience.
  • 7+ years of experience in supply chain, product management, or purchasing roles.
  • Demonstrated ability to lead cross-functional initiatives and operate effectively in a matrixed environment, influencing without authority.
  • Strong analytical, communication, and project management skills.
  • Strategic Pharmaceutical Procurement Expertise: Proven ability to lead procurement strategies within the pharmaceutical industry, including sourcing from third-party manufacturers and navigating complex volume management challenges.
  • Regulatory and Market Acumen: Deep understanding of FDA regulations, DEA compliance, and evolving market dynamics that influence pharmaceutical purchasing decisions and supplier relationships.
  • Advanced Demand Planning & Forecasting: Demonstrated success in designing and implementing demand forecasting models that align with business objectives, mitigate supply disruptions, and optimize inventory levels across diverse product categories.
  • Third-Party Purchasing & Volume Management: Experience managing indirect procurement from external partners, including contract negotiation, performance monitoring, and balancing supply continuity with cost efficiency.
  • Cross-Functional Leadership: Skilled in collaborating across Sales, Finance, IT, and Operations to drive alignment between demand plans and strategic initiatives, while influencing without direct authority in a matrixed environment.
  • Analytical & Operational Excellence: Strong analytical mindset with the ability to translate data into actionable insights, drive continuous improvement, and lead business process redesigns that enhance sourcing efficiency and transparency.
Responsibilities
  • Lead indirect purchasing activities across C1, Northstar, and F&T programs. Manage partner relationships, ensure timely procurement, and maintain accurate purchasing forecasts.
  • Oversee the development and execution of non-performing inventory processes and operational partnerships to align with compliance and inventory goals.
  • Design and implement demand forecasting models to optimize inventory and proactively manage supply disruptions.
  • Drive business process redesign initiatives to improve sourcing efficiency, data transparency, and cross-functional collaboration.
  • Collaborate with Sales, Finance, Pricing, IT, and Supply Chain teams to align demand plans with business objectives and support category expansion.
  • Monitor supplier performance, market trends, and risk indicators to inform purchasing decisions and ensure continuity of supply.

McKesson Corporation operates in the global healthcare sector, focusing on improving patient care through a wide range of products and services. The company works with healthcare providers, pharmacies, and manufacturers to ensure the efficient delivery of medicines and medical products. McKesson acts as a middleman, purchasing medical supplies from manufacturers and distributing them to various healthcare facilities, ensuring that essential items are available when needed. Their revenue comes from selling pharmaceuticals and medical products, as well as providing logistics and supply chain management services. Additionally, McKesson offers technology solutions to help healthcare providers streamline their operations. The company's goal is to facilitate the healthcare supply chain, ensuring that critical medical supplies and services reach patients effectively.

Company Size

N/A

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for telehealth boosts McKesson's logistics capabilities.
  • Personalized medicine trends allow McKesson to leverage its advanced distribution networks.
  • Healthcare data analytics growth offers McKesson expansion opportunities in technology solutions.

What critics are saying

  • Legal challenges from unsolicited fax ads could harm McKesson's reputation.
  • Integration of Community Oncology Revitalization Enterprise Ventures may pose financial risks.
  • Facility closures and layoffs could disrupt operations and affect public perception.

What makes McKesson unique

  • McKesson's extensive distribution network ensures timely delivery of medical products globally.
  • The company offers technology solutions to optimize healthcare provider operations.
  • McKesson's strategic partnerships enhance its role in the global healthcare supply chain.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

401(k) Company Match

Company News

Consumer Financial Services Law Monitor
Jun 20th, 2025
Supreme Court Rules Hobbs Act Does Not Bind District Courts to Agency Interpretations

The case stemmed from McKesson Corporation's allegedly unsolicited fax advertisements sent in violation of the Telephone Consumer Protection Act (TCPA).

Stroock & Stroock & Lavan LLP
Jun 2nd, 2025
McKesson Corporation Completes $2 Billion Notes Offering

Simpson Thacher represented McKesson Corporation in connection with a public offering of $2 billion aggregate principal amount of notes, consisting of $650 million aggregate principal amount of 4.650% Notes due 2030, $650 million aggregate principal amount of 4.950% Notes due 2032 and $700 million aggregate principal amount of 5.250% Notes due 2035. McKesson intends to use the net proceeds from the offering, together with cash on hand and/or commercial paper program borrowings, to fund its acquisition of a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC, an internal business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC.

Slater Sentinel
Mar 26th, 2025
Virtu Financial LLC Makes New $570,000 Investment in McKesson Co. (NYSE:MCK)

Virtu Financial LLC makes new $570,000 Investment in McKesson Co. (NYSE:MCK).

Bizjournals
Mar 18th, 2025
Fortune 50 company puts local facility in midst of closing up for sale

The move came after McKesson informed the state last September that it intended to lay off 13 employees at the facility.

Slater Sentinel
Feb 24th, 2025
Wealthstream Advisors Inc. Invests $218,000 in McKesson Co. (NYSE:MCK)

Wealthstream Advisors Inc. invests $218,000 in McKesson Co. (NYSE:MCK).

INACTIVE